Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The eukaryotic ribosome peptidyl transferase center (PTC) is the catalytic heart of the 60S ribosomal subunit, responsible for forming peptide bonds during protein synthesis (Noller, 2012). While traditionally viewed as a constitutive enzyme, recent research has identified the PTC as a site for context-dependent regulation, where specific nascent polypeptide sequences interact with the PTC and the ribosomal exit tunnel to modulate translation rates (Li et al., 2019). This mechanism has been exploited by small molecules like PF-06446846, which selectively stalls the ribosome during the translation of specific proteins such as PCSK9 (Lintner et al., 2017). By targeting the PTC in a sequence-specific manner, these drugs offer a novel approach to therapeutic intervention, allowing for the modulation of previously undruggable targets by preventing their synthesis at the source. However, ensuring high specificity to avoid global translation inhibition remains a primary challenge in developing drugs for this target.
Sequence-specific or general inhibition of peptide bond formation and translation elongation by binding to the peptidyl transferase center and inducing ribosome stalling through interactions with the nascent polypeptide chain (Lintner et al., 2017; Li et al., 2019).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic ribosome peptidyl transferase center (PTC).